Ocular Tolerance and Intraocular Pressure (IOP) Effects of Zylet Versus Tobradex
Status:
Completed
Trial end date:
2005-06-01
Target enrollment:
Participant gender:
Summary
Phase IV, randomized, double-masked, parallel-group clinical trial comparing the ocular
tolerability and steroid-induced intraocular pressure (IOP) effects of Zylet wth that of
TobraDex in healthy volunteers, when either product was administered QID (at approximately
4-hour intervals) for 28 days.